We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
Vanderbilt researchers developed a nanoparticle that both targets and visualizes cancer cells. Activated by tumor-specific signals, it delivers treatment and enables real-time imaging—advancing precision cancer therapy.
